A major advance in cancer study is emerging with the use of VHH fragments to re-engage damaged p53. This crucial cancer inhibitor protein is frequently inactivated in several forms of malignancies, leading uncontrolled https://bookmarkfly.com/story21938364/nanobodies-reactivate-the-p53-protein-a-new-hope-for-cancer-therapy